연구동향 분석
박사

녹제초 추출물이 파골세포 분화 및 골흡수에 미치는 영향 = Effects of Pyrola japonica Extracts on Osteoclast Differentiation and Bone Resorption

박정식 2016년

논문상세정보
인용/피인용
' 녹제초 추출물이 파골세포 분화 및 골흡수에 미치는 영향 = Effects of Pyrola japonica Extracts on Osteoclast Differentiation and Bone Resorption' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의료과학 약
  • jnk
  • poncirin
  • rankl
  • trap
  • 파골세포
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
187 0

0.0%

' 녹제초 추출물이 파골세포 분화 및 골흡수에 미치는 영향 = Effects of Pyrola japonica Extracts on Osteoclast Differentiation and Bone Resorption' 의 참고문헌

  • 한방재활의학과학회. 한방재활의학 4판
    서울:군자출판사. :133 [2015]
  • 도해 향약(생약) 대사전
    신민교 정보섭 서울:영림사. :779-80 [1990]
  • 대황 추출물이 조골세포와 파골세포의 성장과 활성에 미치는 영향
  • 녹제초의 생약학적 연구
    Do, Won-Im Park, Jong-Hee 도원임 박종희 생약학회지. ;38(1):45-9 [2007]
  • 녹제초 전탕액 투여가 마우스의 면역매개 염증반응 및 면역세포의 기능에 미치는 영향
    노병규 변종호 손인경 송호준 신민교 대한본초학회지. ;13(1):95-117 [1998]
  • 골다공증의 한의학적 인식과 침구치료의 문헌연구
    김동수 김영일 한의학연구소논문집. ;18(1):9-18 [2009]
  • Ye S, Fowler TW, Pavlos HA, et al. LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1. PLoS One. 2011;6(11):e27285.
  • Xu S, Wang Y, Lu J, et al. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Rheumatol International. 2011;32(11):3397-403.
  • Wisutsitthiwong C, Buranaruk C, Pudhom K, et al. The plant limonoid 7-oxo-deacetoxygedunin inhibits RANKL-induced osteoclastogenesis by suppressing activation of the NF-κB and MAPK pathways. Biochemical and Biophysical Research Communications. 2011;415(2):361-6.
  • Thompson WR, Rubin CT, Rubin J. Mechanical regulation of signaling pathways in bone. Gene. 2012;503(2):179-93.
  • Sung B, Oyajobi BO, Aggarwal BB. Plumbagin Inhibits Osteoclastogenesis and Reduces Human Breast Cancer-induced Osteolytic Bone Metastasis in Mice through Suppression of RANKL Signaling. Molecular Cancer Therapeutics. 2011;11(2):350-9.
  • Srinivasan S, Haycraft CJ, Reddy SV, et al. NIP45 negatively regulates RANK ligand induced osteoclast differentiation. Journal of Cellular Biochemistry. 2011;113(4):1274-81.
  • Mukherjee A, Rotwein P. Selective Signaling by Akt1 Controls Osteoblast Differentiation and Osteoblast-mediated Osteoclast Development. Molecular and Cellular Biology. 2011;32(2):490-500.
  • Michou L, Brown JP. Genetics of bone diseases: Paget's disease, fibrous dysplasia, osteopetrosis, and osteogenesis imperfecta. Joint Bone Spine. 2011;78(3):252-8.
  • Matsumor T. New extension and future trends in study of RANKL-RANK. Clinical Calcium. 2011;21(8):1119-20.
  • Mabilleau G, Pascaretti-Grizon F, Basl MF, et al. Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT. Cytokine. 2012;57(2):294-9.
  • Liu BY, Wu PW, Bringhurst FR, et al. Estrogen inhibition of PTH-stimulated osteoclast formation and attachment in vitro: involvement of both PKA and PKC. Endocrinology. 2002;143(2):627-35.
  • Kim JS, Shim SH, Xu YN, et al. Phenolic glycosides from Pyrola japonica. Chemical & Pharmaceutical Bulletin. 2004;52(6):714-7.
  • Hiasa M, Abe M, Nakano A, Oda A, et al. GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme(TACE). Blood. 2009;114(20):4517-26.
  • Henriksen K, Karsdal MA, Taylor A, et al. Generation of human osteoclasts from peripheral blood. Methods in Molecular Biology. 2012;816:159-75.
  • Goode A, Layfield R. Recent advances in understanding the molecular basis of Paget disease of bone. Journal of Clinical Pathology. 2010;63(3):199-203.
  • Fujisaki, K., Tanabe N, Suzuki N, et al. Receptor activator of NF-kappa B ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Life Sciences. 2007;80(14):1311-8.
  • Dougall WC. Osteoclast-dependent and-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clinical Cancer Research. 2012;18(2):326-35.
  • Dore RK. The RANKL pathway and denosumab. Rheumatic Disease Clinics of North America. 2011;37(3):433-52.
  • Chang EJ, Ha J, Huang H, et al. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. Journal of Cell Science. 2008;121(15):2555-64.
  • Almeida M, Han L, Ambrogini E, et al. Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts. The Journal of Biological Chemistry. 2011;286(52):44326-35.